TY - JOUR
T1 - Health-related quality of life in small-cell lung cancer
T2 - A systematic review on reporting of methods and clinical issues in randomised controlled trials
AU - Zikos, Efstathios
AU - Ghislain, Irina
AU - Coens, Corneel
AU - Ediebah, Divine E.
AU - Sloan, Elizabeth
AU - Quinten, Chantal
AU - Koller, Michael
AU - van Meerbeeck, Jan P.
AU - Flechtner, Hans Henning
AU - Stupp, Roger
AU - Pallis, Athanasios
AU - Czimbalmos, Agnes
AU - Sprangers, Mirjam A G
AU - Bottomley, Andrew
PY - 2014/2
Y1 - 2014/2
N2 - Small-cell lung cancer represents about 15% of all lung cancers; increasingly, randomised controlled trials of this disease measure the health-related quality of life of patients. In this Systematic Review we assess the adequacy of reporting of health-related quality-of-life methods in randomised controlled trials of small-cell lung cancer, and the potential effect of this reporting on clinical decision making. Although overall reporting of health-related quality of life was acceptable, improvements are needed to optimise the use of health-related quality of life in randomised controlled trials.
AB - Small-cell lung cancer represents about 15% of all lung cancers; increasingly, randomised controlled trials of this disease measure the health-related quality of life of patients. In this Systematic Review we assess the adequacy of reporting of health-related quality-of-life methods in randomised controlled trials of small-cell lung cancer, and the potential effect of this reporting on clinical decision making. Although overall reporting of health-related quality of life was acceptable, improvements are needed to optimise the use of health-related quality of life in randomised controlled trials.
UR - http://www.scopus.com/inward/record.url?scp=84892956730&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84892956730&partnerID=8YFLogxK
U2 - 10.1016/S1470-2045(13)70493-5
DO - 10.1016/S1470-2045(13)70493-5
M3 - Review article
C2 - 24480558
AN - SCOPUS:84892956730
VL - 15
SP - e78-89
JO - The Lancet Oncology
JF - The Lancet Oncology
SN - 1470-2045
IS - 2
ER -